Cartesian Therapeutics Inc.
RNAC
$7.06+3.45%
End of day · as of Oct 10, 2026, 2:00 PM ET
Mkt cap
$290.95M
EV/Sales
59.3
P/E ratio
N/A
FY2025 Revenue
$2.80M
EPS (TTM)
$-5.78
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-4658.63%
Beta
0.83
Div yield
N/A
Sector
Healthcare
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported RNAC revenue for 2025-12-31 was $2.8M. Net income was -$130.3M. Revenue was down 92.8% from 2024-12-31 to 2025-12-31. RNAC currently screens at market cap $290.9M.
Use this RNAC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full RNAC income, balance, and cash tables.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company in the Healthcare sector.
Latest cached Cartesian Therapeutics Inc. (RNAC) revenue for Dec 31, 2025 was $2.8M. Net income was -$130.3M. Statements: https://lician.com/financials/rnac
Cartesian Therapeutics Inc. (RNAC) market capitalization is $290.9M on the latest cached snapshot.
Cartesian Therapeutics Inc. (RNAC) cached previous close $6.82; day range $6.85 – $7.17; volume 114,544. Session quote: https://lician.com/quote/rnac
Cartesian Therapeutics Inc. (RNAC) latest cached earnings event is "RNAC earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached RNAC filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/rnac